SWOG clinical trial number
SWOG-8300

Treatment of Limited Non-Small Cell Lung Cancer: Radiation Versus Radiation Plus Chemotherapy (FOMi/CAP)

Closed
Phase
Published
Abbreviated Title
Treatment of Limited Non-Small Cell Lung Cancer: Radiation Versus Radiation Plus Chemotherapy (FOMi/CAP)
Activated
07/20/1984
Closed
03/01/1988

Research committees

Lung Cancer

Publication Information Expand/Collapse

2005

Southwest Oncology Group: Two decades of experience in non-small cell lung cancer

AT Turrisi;J Crowley;K Albain;L Gaspar;D Gandara Seminars in Oncology 32(2Suppl3):S119-S121

PMid: PMID16015548

2002

Factorial design considerations

S Green;PY Liu;J O'Sullivan Journal of Clinical Oncology 20(16):3424-3430

1998

A randomized trial of chemotherapy and Radiotherapy for stage III non-small cell lung cancer.

TP Miller;JJ Crowley;JG Mira;JG Schwartz;L Hutchins;L Baker;R Natale;EM Chase;RB Livingston Cancer Therapeutics 1(4):229-236

Other Clinical Trials

SWOG Clinical Trial Number
S2409

PRISM: PRecIsion in SCLC via a Multicohort Study: Randomized Phase II studies evaluating maintenance Durvalumab with or without Biomarker-Directed Therapy for Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Research Committee(s)
Lung Cancer
Activated
09/08/2025
Accrual
0%
Open
Phase
SWOG Clinical Trial Number
CTSU/EA5231

A Randomized Phase III Trial of Checkpoint Blockade in Lung Cance3r Patients in the Adjuvant Setting Based on Pathologic Response Following Neoadjuvant Therapy (CLEAR)
Research Committee(s)
Lung Cancer
Activated
06/13/2025
Open
Phase
SWOG Clinical Trial Number
S2414

INcorporating pathologic reSponse in patIents with early staGe lung cancer to optimize immunotHerapy in the adjuvanT setting (INSIGHT)
Research Committee(s)
Lung Cancer
Symptom Management and Survivorship
Activated
03/14/2025
Accrual
2%
Open
Phase